(Bloomberg) — Novartis AG agreed to purchase MorphoSys AG for €2.7 billion ($2.9 billion) because the Swiss pharma firm begins…
Browsing: Novartis
Need to keep on high of the science and politics driving biotech immediately? Join to get our biotech e-newsletter in your inbox.…
We have detected you might be on Web Explorer. For the very best Barrons.com expertise, please replace to a contemporary…
(Bloomberg) — Clovis Oncology Inc. filed for chapter and plans to promote its experimental most cancers drug at an public…